Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 536156, 8 pages
http://dx.doi.org/10.1155/2012/536156
Clinical Study

Circulating Leukotriene B4 Identifies Respiratory Complications after Trauma

Department of Trauma, Hand and Reconstructive Surgery, Hospital of the Goethe University Frankfurt am Main, 60590 Frankfurt, Germany

Received 22 August 2011; Accepted 9 December 2011

Academic Editor: Michael Frink

Copyright © 2012 Birgit Auner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Probst, H. C. Pape, F. Hildebrand et al., “30 years of polytrauma care: an analysis of the change in strategies and results of 4849 cases treated at a single institution,” Injury, vol. 40, no. 1, pp. 77–83, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Nast-Kolb, M. Aufmkolk, S. Rucholtz, U. Obertacke, and C. Waydhas, “Multiple organ failure still a major cause of morbidity but not mortality in blunt multiple trauma,” Journal of Trauma—Injury, Infection and Critical Care, vol. 51, no. 5, pp. 835–842, 2001. View at Google Scholar · View at Scopus
  3. P. R. Miller, M. A. Croce, P. D. Kilgo, J. Scott, and T. C. Fabian, “Acute respiratory distress syndrome in blunt trauma: identification of independent risk factors,” American Surgeon, vol. 68, no. 10, pp. 845–850, 2002. View at Google Scholar · View at Scopus
  4. T. M. Osborn, J. K. Tracy, J. R. Dunne, M. Pasquale, and L. M. Napolitano, “Epidemiology of sepsis in patients with traumatic injury,” Critical Care Medicine, vol. 32, no. 11, pp. 2234–2240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Dushianthan, M. P. Grocott, A. D. Postle, and R. Cusack, “Acute respiratory distress syndrome and acute lung injury,” Postgraduate Medical Journal, vol. 87, no. 1031, pp. 612–622, 2011. View at Google Scholar
  6. A. Esteban, A. Anzueto, F. Frutos et al., “Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study,” Journal of the American Medical Association, vol. 287, no. 3, pp. 345–355, 2002. View at Google Scholar · View at Scopus
  7. C. Brun-Buisson, C. Minelli, G. Bertolini et al., “Epidemiology and outcome of acute lung injury in European intensive care units Results from the ALIVE study,” Intensive Care Medicine, vol. 30, no. 1, pp. 51–61, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Villar, L. Perez-Mendez, J. Lopez et al., “An early PEEP/FIO2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 8, pp. 795–804, 2007. View at Publisher · View at Google Scholar
  9. S. E. Erickson, G. S. Martin, J. L. Davis, M. A. Matthay, and M. D. Eisner, “Recent trends in acute lung injury mortality: 1996–2005,” Critical Care Medicine, vol. 37, no. 5, pp. 1574–1579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H. C. Pape, D. Rixen, J. Morley et al., “Impact of the method of initial stabilization for femoral shaft fractures in patients with multiple injuries at risk for complications (borderline patients),” Annals of Surgery, vol. 246, no. 3, pp. 491–499, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Raymondos, M. U. Martin, T. Schmudlach et al., “Early alveolar and systemic mediator release in patients at different risks for ARDS after multiple trauma,” Injury, vol. 43, no. 2, pp. 189–195, 2012. View at Publisher · View at Google Scholar
  12. A. S. Cowburn, A. M. Condliffe, N. Farahi, C. Summers, and E. R. Chilvers, “Advances in neutrophil biology: clinical implications,” Chest, vol. 134, no. 3, pp. 606–612, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Y. Lee, S. C. Ho, H. C. Lin et al., “Neutrophil-derived elastase induces TGF-β1 secretion in human airway smooth muscle via NF-κB pathway,” American Journal of Respiratory Cell and Molecular Biology, vol. 35, no. 4, pp. 407–414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. P. J. Barnes, “New molecular targets for the treatment of neutrophilic diseases,” Journal of Allergy and Clinical Immunology, vol. 119, no. 5, pp. 1055–1062, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Aggarwal, C. S. Baker, T. W. Evans, and P. L. Haslam, “G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome,” European Respiratory Journal, vol. 15, no. 5, pp. 895–901, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. Donnelly, R. M. Strieter, S. L. Kunkel et al., “Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups,” Lancet, vol. 341, no. 8846, pp. 643–647, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. S. W. Crooks and R. A. Stockley, “Leukotriene B4,” International Journal of Biochemistry and Cell Biology, vol. 30, no. 1, pp. 173–178, 1998. View at Google Scholar
  18. A. Sala, S. Zarini, and A. Bolla, “Leukotrienes: Llipid bioeffectors of inflammatory reactions,” Biochemistry, vol. 63, no. 1, pp. 84–92, 1998. View at Google Scholar · View at Scopus
  19. P. Borgeat and B. Samuelsson, “Metabolism of arachidonic acid in polymorphonuclear leukocytes. Structural analysis of novel hydroxylated compounds,” Journal of Biological Chemistry, vol. 254, no. 16, pp. 7865–7869, 1979. View at Google Scholar · View at Scopus
  20. P. Borgeat, M. Nadeau, H. Salari, P. Poubelle, and B. Fruteau de Laclos, “Leukotrienes: biosynthesis, metabolism, and analysis,” Advances in Lipid Research, vol. 21, pp. 47–77, 1985. View at Google Scholar · View at Scopus
  21. M. Peters-Golden and W. R. Henderson Jr, “Leukotrienes,” New England Journal of Medicine, vol. 357, no. 18, pp. 1798–1854, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. P. T. Monteiro, C. S. Pinheiro, T. Luna-Gomes et al., “Leukotriene B4 mediates neutrophil migration induced by heme,” Journal of Immunology, vol. 186, no. 11, pp. 6562–6567, 2011. View at Publisher · View at Google Scholar
  23. A. W. Ford-Hutchinson, M. A. Bray, and M. V. Doig, “Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes,” Nature, vol. 286, no. 5770, pp. 264–265, 1980. View at Google Scholar · View at Scopus
  24. M. J. H. Smith, A. W. Ford-Hutchinson, and M. A. Bray, “Leukotriene B: a potential mediator of inflammation,” Journal of Pharmacy and Pharmacology, vol. 32, no. 7, pp. 517–518, 1980. View at Google Scholar · View at Scopus
  25. A. Hicks, S. P. Monkarsh, A. F. Hoffman, and R. Goodnow, “Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments,” Expert Opinion on Investigational Drugs, vol. 16, no. 12, pp. 1909–1920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. J. R. Masclans, J. Sabater, J. Sacanell et al., “Possible prognostic value of leukotriene B4 in acute respiratory distress syndrome,” Respiratory Care, vol. 52, no. 12, pp. 1695–1700, 2007. View at Google Scholar · View at Scopus
  27. A. H. Stephenson, A. J. Lonigro, T. M. Hyers, R. O. Webster, and A. A. Fowler, “Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS,” American Review of Respiratory Disease, vol. 138, no. 3, pp. 714–719, 1988. View at Google Scholar · View at Scopus
  28. A. Antczak, W. Piotrowski, J. Marczak, M. Ciebiada, P. Gorski, and P. J. Barnes, “Correlation between eicosanoids in bronchoalveolar lavage fluid and in exhaled breath condensate,” Disease Markers, vol. 30, no. 5, pp. 213–220, 2011. View at Publisher · View at Google Scholar
  29. J. C. Eun, E. E. Moore, A. Banerjee et al., “Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce pro-inflammatory activation of human pulmonary microvascular endothelial cells,” Shock, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. C. C. Silliman, “The two-event model of transfusion-related acute lung injury,” Critical Care Medicine, vol. 34, supplement 5, pp. S124–S131, 2006. View at Publisher · View at Google Scholar
  31. F. A. Moore and E. E. Moore, “Evolving concepts in the pathogenesis of postinjury multiple organ failure,” Surgical Clinics of North America, vol. 75, no. 2, pp. 257–277, 1995. View at Google Scholar · View at Scopus
  32. D. A. Partrick, F. A. Moore, E. E. Moore, C. C. Barnett, and C. C. Silliman, “Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure,” New Horizons, vol. 4, no. 2, pp. 194–210, 1996. View at Google Scholar · View at Scopus
  33. E. Von Elm, D. G. Altman, M. Egger, S. J. Pocock, P. C. Gøtzsche, and J. P. Vandenbroucke, “The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting of observational studies,” Internist, vol. 49, no. 6, pp. 688–693, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. “Rating the severity of tissue damage. I. The abbreviated scale,” Journal of the American Medical Association, vol. 215, no. 2, pp. 277–280, 1971. View at Publisher · View at Google Scholar
  35. “Rating the severity of tissue damage. II. The comprehensive scale,” Journal of the American Medical Association, vol. 220, no. 5, pp. 717–720, 1972. View at Publisher · View at Google Scholar
  36. Association for the Advancement of Automotive Medicine (AAAM), Abbreviated Injury Scale 1990 Revision Update 1998, Association for the Advancement of Automotive Medicine, Seattle, Wash, USA, 1998.
  37. S. P. Baker, B. O'Neill, W. Haddon, and W. B. Long, “The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care,” Journal of Trauma, vol. 14, no. 3, pp. 187–196, 1974. View at Google Scholar · View at Scopus
  38. T. T. Bauer, J. Lorenz, K. F. Bodmann, and F. Vogel, “Abbreviated guidelines for prevention, diagnostics, and therapy of nosocomial pneumonia,” Medizinische Klinik, vol. 100, no. 6, pp. 355–360, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. G. R. Bernard, A. Artigas, K. L. Brigham et al., “The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 3, pp. 818–824, 1994. View at Google Scholar · View at Scopus
  40. M. Bhatia and S. Moochhala, “Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome,” Journal of Pathology, vol. 202, no. 2, pp. 145–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. H. C. Pape, T. Tsukamoto, P. Kobbe, I. Tarkin, S. Katsoulis, and A. Peitzman, “Assessment of the clinical course with inflammatory parameters,” Injury, vol. 38, no. 12, pp. 1358–1364, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. G. Muehlstedt, M. Lyte, and J. L. Rodriguez, “Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia,” Shock, vol. 17, no. 6, pp. 443–450, 2002. View at Google Scholar · View at Scopus
  43. M. Peters-Golden and T. G. Brock, “5-Lipoxygenase and FLAP,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 69, no. 2-3, pp. 99–109, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Antonelli, G. Raponi, L. Lenti et al., “Leukotrienes and alpha tumor necrosis factor levels in the bronchoalveolar lavage fluid of patient at risk for the adult respiratory distress syndrome,” Minerva Anestesiologica, vol. 60, no. 9, pp. 419–426, 1994. View at Google Scholar · View at Scopus
  45. G. W. Schmid-Schonbein, “Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation,” Federation Proceedings, vol. 46, no. 7, pp. 2397–2401, 1987. View at Google Scholar · View at Scopus
  46. A. Toda, T. Yokomizo, and T. Shimizu, “Leukotriene B4 receptors,” Prostaglandins and Other Lipid Mediators, vol. 68-69, pp. 575–585, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. D. M. Guidot, M. J. Repine, J. Y. Westcott, and J. E. Repine, “Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 17, pp. 8156–8159, 1994. View at Publisher · View at Google Scholar · View at Scopus
  48. J. W. Edens, K. K. Chung, J. C. Pamplin et al., “Predictors of early acute lung injury at a combat support hospital: a prospective observational study,” Journal of Trauma—Injury, Infection and Critical Care, vol. 69, no. 1, pp. S81–S85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. P. R. Miller, M. A. Croce, T. K. Bee et al., “ARDS after pulmonary contusion: accurate measurement of contusion volume identifies high-risk patients,” Journal of Trauma—Injury, Infection and Critical Care, vol. 51, no. 2, pp. 223–230, 2001. View at Google Scholar · View at Scopus
  50. S. Ruchholtz, R. Lefering, T. Paffrath et al., “Reduction in mortality of severely injured patients in Germany,” Deutsches Arzteblatt, vol. 105, no. 13, pp. 225–231, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. N. O. Skaga, T. Eken, J. M. Jones, and P. A. Steen, “Different definitions of patient outcome: consequences for performance analysis in trauma,” Injury, vol. 39, no. 5, pp. 612–622, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. O. BrattstrÖm, F. Granath, P. Rossi, and A. Oldner, “Early predictors of morbidity and mortality in trauma patients treated in the intensive care unit,” Acta Anaesthesiologica Scandinavica, vol. 54, no. 8, pp. 1007–1017, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Ulvik, R. Kvåle, T. Wentzel-Larsen, and H. Flaatten, “Multiple organ failure after trauma affects even long-term survival and functional status,” Critical Care, vol. 11, no. 5, article R95, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. M. L. Walker, P. S. Owen, C. Sampson, J. Marshall, T. Pounds, and V. J. Henderson, “Incidence and outcomes of critical illness-related corticosteroid insufficiency in trauma patients,” American Surgeon, vol. 77, no. 5, pp. 579–585, 2011. View at Google Scholar
  55. L. G. Glance, P. W. Stone, D. B. Mukamel, and A. W. Dick, “Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients,” Archives of Surgery, vol. 146, no. 7, pp. 794–801, 2011. View at Publisher · View at Google Scholar
  56. T. Lustenberger, M. Turina, B. Seifert, L. Mica, and M. Keel, “The severity of injury and the extent of hemorrhagic shock predict the incidence of infectious complications in trauma patients,” European Journal of Trauma and Emergency Surgery, vol. 35, no. 6, pp. 538–546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Wutzler, A. Wafaisade, M. Maegele et al., “Lung organ failure score (LOFS): probability of severe pulmonary organ failure after multiple injuries including chest trauma,” Injury. In press. View at Publisher · View at Google Scholar